chr1-84408465-A-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_058248.2(DNASE2B):c.-293A>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_058248.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNASE2B | NM_021233.3 | c.332A>C | p.Asn111Thr | missense_variant | Exon 3 of 6 | ENST00000370665.4 | NP_067056.2 | |
DNASE2B | NM_058248.2 | c.-293A>C | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 4 | NP_490649.1 | |||
DNASE2B | XM_047426625.1 | c.95A>C | p.Asn32Thr | missense_variant | Exon 2 of 5 | XP_047282581.1 | ||
DNASE2B | NM_058248.2 | c.-293A>C | 5_prime_UTR_variant | Exon 1 of 4 | NP_490649.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNASE2B | ENST00000370662 | c.-293A>C | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 4 | 1 | ENSP00000359696.3 | ||||
DNASE2B | ENST00000370665.4 | c.332A>C | p.Asn111Thr | missense_variant | Exon 3 of 6 | 1 | NM_021233.3 | ENSP00000359699.3 | ||
DNASE2B | ENST00000370662 | c.-293A>C | 5_prime_UTR_variant | Exon 1 of 4 | 1 | ENSP00000359696.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.332A>C (p.N111T) alteration is located in exon 3 (coding exon 3) of the DNASE2B gene. This alteration results from a A to C substitution at nucleotide position 332, causing the asparagine (N) at amino acid position 111 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.